Rosetta Genomics Gets NY State Permit for microRNA Tests | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics has received a clinical laboratory permit from the New York State Department of Health allowing the firm to offer its microRNA-based tests to physicians and patients in the state.

The firm currently sells three tests — the miRview meso, miRview mets, and miRview squamous — that are run at its own Philadelphia-based CAP-accredited, CLIA-certified lab.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.